Palbociclib and Valtrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Palbociclib (palbociclib) and Valtrex (valacyclovir hydrochloride). Common drug interactions include thrombocytopenia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Palbociclib and Valtrex. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Palbociclib?

Palbociclib has active ingredients of palbociclib. eHealthMe is studying from 11,622 Palbociclib users. Check the latest studies of Palbociclib.

What is Valtrex?

Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 39,999 Valtrex users. Check the latest studies of Valtrex.



On Jul, 24, 2026

16 people who take Palbociclib and Valtrex together, and have interactions are studied.

Palbociclib and Valtrex drug interactions.

What are the common drug interactions of Palbociclib and Valtrex, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Hypersensitivity
  3. Cough
  4. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  5. Oxygen saturation decreased
  6. Blood creatinine increased
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Abdominal pain

male:

  1. Abdominal pain
  2. Cholecystitis acute (rapid infection of gallbladder)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Unresponsive to stimuli
  5. Back pain
  6. Cold sweat
  7. Hypoxia (low oxygen in tissues)
  8. Lethargy (tiredness)
  9. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  10. Pyrexia (fever)

What are the common drug interactions of Palbociclib and Valtrex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cough
  2. Oxygen saturation decreased
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Bronchial obstruction (blockage of the breathing passages to the lungs)
  5. Chest pain
  6. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  7. Granuloma (a small area of inflammation due to tissue injury)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Headache (pain in head)
  10. Hilar lymphadenopathy (disease of the lymph nodes due to infection)

40-49:

  1. Hypersensitivity

50-59:

  1. Blood creatinine increased
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Abdominal pain
  2. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  3. Pyrexia (fever)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Unresponsive to stimuli
  8. Cholecystitis acute (rapid infection of gallbladder)
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Back pain

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 11 people, 68.75%
  2. Pain: 7 people, 43.75%
  3. Headache (pain in head): 6 people, 37.50%
  4. Nausea (feeling of having an urge to vomit): 6 people, 37.50%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 31.25%
  6. Muscle Aches (muscle pain): 5 people, 31.25%
  7. Insomnia (sleeplessness): 5 people, 31.25%
  8. Joint Pain: 5 people, 31.25%
  9. Stomatitis (inflammation of mucous membrane of mouth): 5 people, 31.25%
  10. Asthma: 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Palbociclib and Valtrex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Palbociclib and Valtrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Palbociclib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valtrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Palbociclib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valtrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on palbociclib and valacyclovir hydrochloride (the active ingredients of Palbociclib and Valtrex, respectively), and Palbociclib and Valtrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: